Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis

医学 帕洛诺塞隆 化疗引起恶心呕吐 止吐药 恶心 消炎药 重症监护医学 奥氮平 内科学 肿瘤科 麻醉 精神科 精神分裂症(面向对象编程)
作者
James Natale
出处
期刊:Hospital practice [Taylor & Francis]
卷期号:43 (4): 226-234 被引量:18
标识
DOI:10.1080/21548331.2015.1077095
摘要

This review provides background information on chemotherapy-induced nausea and vomiting (CINV) classification and pathophysiology and reviews various antiemetic agents for CINV prophylaxis, including corticosteroids, serotonin receptor antagonists (5-HT3 RAs), tachykinin NK1 receptor antagonists (NK1 RAs), and olanzapine. Other less commonly used agents are briefly discussed. Practical considerations are reviewed as well, including emetogenicity of chemotherapeutic regimens, patient-specific risk factors for CINV, principles of CINV management, health economics outcome research, and quality of life. Available data on the newly FDA-approved antiemetic combination netupitant/palonosetron (NEPA) is also reviewed. Prevention of CINV is an important goal in managing patients with cancer and is especially difficult with respect to nausea and delayed CINV. Corticosteroids are a mainstay of CINV prophylaxis and are usually given in combination with other therapies. The 5-HT3 RA palonosetron has shown increased efficacy over other agents in the same class for prevention of delayed emesis with moderately emetogenic chemotherapy and NK1 RAs improve emesis prevention in combination with 5-HT3 RAs and dexamethasone. Olanzapine has shown efficacy for CINV prophylaxis and the treatment of breakthrough CINV. The new combination therapy, NEPA, has been shown to be efficacious for the prevention of acute, delayed, and overall CINV. Risk factors that have been identified for CINV include gender, age, and alcohol intake. It is important to assess the emetogenicity of chemotherapy regimens as well as the potential impact of patient risk factors in order to provide adequate prophylaxis. Acute and delayed CINV are severe, burdensome side effects of chemotherapy; however, new data on prevention and the discovery of new agents can further improve CINV control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nura发布了新的文献求助10
刚刚
小6s发布了新的文献求助10
刚刚
沉静冬灵应助吉小聿采纳,获得20
刚刚
2秒前
2秒前
2秒前
玺鱼完成签到,获得积分10
4秒前
5秒前
淡淡天蓝完成签到,获得积分10
5秒前
陈美净完成签到,获得积分10
5秒前
科研通AI5应助义气萝卜头采纳,获得10
5秒前
5秒前
6秒前
hsh发布了新的文献求助10
6秒前
杜景婷完成签到 ,获得积分10
7秒前
8秒前
8秒前
mm发布了新的文献求助10
8秒前
9秒前
洋洋麻麻发布了新的文献求助10
10秒前
清脆的雁丝完成签到,获得积分10
10秒前
xn201120发布了新的文献求助10
10秒前
早日毕业发布了新的文献求助10
11秒前
FashionBoy应助独特的苗条采纳,获得10
11秒前
JamesPei应助yuaasusanaann采纳,获得10
11秒前
12秒前
Mason发布了新的文献求助10
13秒前
14秒前
shen完成签到,获得积分10
14秒前
星海梦幻完成签到 ,获得积分10
15秒前
量子星尘发布了新的文献求助10
15秒前
巧稚一生完成签到 ,获得积分10
17秒前
17秒前
18秒前
mm完成签到,获得积分10
20秒前
shen发布了新的文献求助10
20秒前
xphpyy给xphpyy的求助进行了留言
21秒前
hsh完成签到,获得积分10
22秒前
爆米花应助洋洋麻麻采纳,获得10
22秒前
小6s完成签到,获得积分10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976210
求助须知:如何正确求助?哪些是违规求助? 3520366
关于积分的说明 11203088
捐赠科研通 3256965
什么是DOI,文献DOI怎么找? 1798570
邀请新用户注册赠送积分活动 877738
科研通“疑难数据库(出版商)”最低求助积分说明 806516